Ryoko Kuromatsu
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 62
- Hepatitis C virus research 17
- Liver Disease and Transplantation 14
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 11
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 29
- Hepatitis B Virus Studies 11
-
- Cancer Mechanisms and Therapy 10
- Oncology top 5%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 18
- Co-authors
- Michio SataShuji SumieKoji OkudaTakuji TorimuraMasatoshi TanakaEiji AndoMasahito NakanoTakashi Niizeki
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)Gastroenterology (1 paper)
- Partner nations
- JapanUnited StatesSingapore
In The Last Decade
Ryoko Kuromatsu
85 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Hepatology 2.0k
- Cancer Research 485
- Epidemiology 888
- Pathology and Forensic Medicine 454
- Oncology 606
Countries citing papers authored by Ryoko Kuromatsu
This map shows the geographic impact of Ryoko Kuromatsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryoko Kuromatsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryoko Kuromatsu more than expected).
Fields of papers citing papers by Ryoko Kuromatsu
This network shows the impact of papers produced by Ryoko Kuromatsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryoko Kuromatsu. The network helps show where Ryoko Kuromatsu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ryoko Kuromatsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 14 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 11 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 12 | |
| 11 | 2021 | 5 | |
| 12 | 2021 | 6 | |
| 13 | 2021 | 39 | |
| 14 | 2021 | 37 | |
| 15 | 2021 | 15 | |
| 16 | 2020 | 18 | |
| 17 | 2020 | 54 | |
| 18 | 2020 | 44 | |
| 19 | 2019 | 187 | |
| 20 | 2009 | 22 |
About Ryoko Kuromatsu
Ryoko Kuromatsu is a scholar working on Hepatology, Cancer Research and Epidemiology, having authored 88 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (62 papers), Liver Disease Diagnosis and Treatment (29 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers), Hepatitis C virus research (17 papers), Liver Disease and Transplantation (14 papers), Hepatitis B Virus Studies (11 papers), Cancer, Lipids, and Metabolism (11 papers) and Cancer Mechanisms and Therapy (10 papers). The work is most often cited by research in Hepatology (2.0k citations), Cancer Research (485 citations) and Epidemiology (888 citations). Ryoko Kuromatsu has collaborated with scholars based in Japan, United States and Singapore. Frequent co-authors include Michio Sata, Shuji Sumie, Koji Okuda, Takuji Torimura, Masatoshi Tanaka, Eiji Ando, Masahito Nakano, Takashi Niizeki, Shusuke Okamura and Akio Takata. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.